Why is GKB Ophthalmics falling/rising?

As of 23-Sep, GKB Ophthalmics Ltd is currently priced at 69.80, reflecting an increase of 0.29 or 0.42%. The stock has shown a trend reversal, gaining after two consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend overall. Additionally, the stock has underperformed significantly over various periods, with a year-to-date decline of 29.32% compared to a 5.07% increase in the Sensex. The delivery volume has also decreased sharply, falling by 68.99% against the 5-day average, suggesting a decline in investor participation.
In the broader market context, the stock's performance over the past week shows a decline of 5.68%, while the Sensex has only decreased by 0.34%, indicating that GKB Ophthalmics is lagging behind the benchmark. Despite today's slight uptick, the overall trend remains negative, with substantial losses over the past year and three years compared to the Sensex's gains. This context highlights the challenges faced by GKB Ophthalmics in attracting investor interest and maintaining momentum in a market that is otherwise showing resilience.